In vitro amoebicidal activity of Origanum syriacum and Origanum laevigatum on Acanthamoeba castellanii cysts and trophozoites

Experimental Parasitology

Volumn 131, Issue 1, 2012, Pages 20-24

  Degerli, Serpil ^a   Tepe, Bektas ^a   Celiksoz, Ali ^a   Berk, Seyda ^a   Malatyali, Erdogan ^a  

^a CUMHURIYET UNIVERSITY   (Turkey)

Author keywords

Acanthamoeba castellanii; Amoebicidal activity; Cyst; Origanum laevigatum; Origanum syriacum; Trophozoite

Indexed keywords

METHANOL; ORIGANUM LAEVIGATUM EXTRACT; ORIGANUM SYRIACUM EXTRACT; PLANT EXTRACT; UNCLASSIFIED DRUG;

ACANTHAMOEBA CASTELLANII; AMOEBICIDAL ACTIVITY; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYST (RESTING STAGE); DRUG ACTIVITY; DRUG RESISTANCE; DRUG SCREENING; IN VITRO STUDY; NONHUMAN; ORIGANUM; ORIGANUM LAEVIGATUM; ORIGANUM SYRIACUM; PRIORITY JOURNAL; TROPHOZOITE;

ACANTHAMOEBA CASTELLANII; AMEBICIDES; DOSE-RESPONSE RELATIONSHIP, DRUG; METHANOL; OOCYSTS; ORIGANUM; PLANT EXTRACTS; SOLVENTS; TIME FACTORS; TROPHOZOITES;

ACANTHAMOEBA CASTELLANII; ORIGANUM LAEVIGATUM; ORIGANUM SYRIACUM;

EID: 84860295118     PISSN: 00144894     EISSN: 10902449     Source Type: Journal    
DOI: 10.1016/j.exppara.2012.02.020     Document Type: Article

References (50)

1. Akin Polat Z., Tepe B., Vural A. In vitro amoebicidal activity of Thymus sipyleus subsp. sipyleus var. sipyleus on Acanthamoeba castellanii and its cytotoxic potential on corneal cells. Parasitology Research 2007, 101:1551-1555.
2. Akin Polat Z., Vural A., Tepe B., Cetin A. In vitro amoebicidal activity of four Allium species on Acanthamoeba castellanii and their cytotoxic potentials on corneal cells. Parasitology Research 2007, 101:397-402.
3. Akin Polat Z., Vural A., Ozan F., Tepe B., Ozcelik S., Cetin A. In vitro effect of garlic (Allium sativum) extract on Acanthamoeba castellanii and its cytotoxic potential on corneal cells. Journal of Ocular Pharmacology and Therapeutics 2008, 24:8-14.
4. Aligiannis N., Kalpoutzakis E., Mitaku S., Chinou I.B. Composition and antimicrobial activity of the essential oils of two Origanum species. Journal of Agricultural and Food Chemistry 2001, 49:4168-4170.
5. Arrieta J., Reyes B., Calzada F., Cedillo-Rivera R. Amoebicidal and giardicidal compounds from the leaves of Zanthoxylum liebmannianun. Fitoterapia 2001, 72:295-297.
6. Baser K.H.C., Ozek T., Tumen G., Sezik E. Composition of the essential oils of Turkish Origanum species with commercial importance. Journal of Essential Oil Research 1993, 5:619-623.
7. Callicott J.G. Amebic meningoencephalitis due to free-living amebas of the Hartmannella (Acanthamoeba)-Naegleria group. American Journal of Clinical Pathology 1968, 49:84-91.
8. Chu D.M., Miles H., Toney D., Ngyuen C., Marciano-Cabral F. Amebicidal activity of plant extracts from Southeast Asia on Acanthamoeba spp. Parasitology Research 1998, 84:746-752.
9. Rayo Camacho Corona M., Croft S.L., Phillipson J.D. Natural products as sources of antiprotozoal drugs. Current Opinion in Anti-Infective Investigational Drugs 2000, 2:47-62.
10. De Jonckheere J.F. Ecology of Acanthamoeba. Reviews of Infectious Diseases 1991, 13:S385-S387.
11. Derda M., Hadas E., Thiem B. Plant extracts as natural amoebicidal agents. Parasitology Research 2009, 104:705-708.
12. Dougherty P.J., Binder P.S., Mondino B.J., Glasgow B.J. Acanthamoeba sclerokeratitis. American Journal of Ophthalmology 1994, 117:475-479.
13. Ficker L., Seal D., Warhurst D., Wright P. Acanthamoeba keratitis-resistance to medical therapy. Eye 1990, 4:835-838.
14. Fowler M., Carter R.F. Acute pyogenic meningitis probably due to Acanthamoeba spp.: a preliminary report. British Medicinal Journal 1965, 2:740-742.
15. Garcia, L.S., Brucker, D.A., 1993. Diagnostic Medical Parasitology, second ed. American Society for Microbiology Press, Washington, pp. 601.
16. Gotsiou P., Naxakis G., Skoula M. Diversity in the composition of monoterpenoids of Origanum microphyllum (Labiatae). Biochemical Systematics and Ecology 2002, 30:865-879.
17. Goze I., Dag S., Tepe B., Akin Polat Z. In vitro amoebicidal activity of Salvia staminea and S. caespitosa on Acanthamoeba castellanii and their cytotoxic potentials on corneal cells. Journal of Ocular Pharmacology and Therapeutics 2009, 25:293-298.
18. Holzgrabe U., Bechthold A. Paradigmenwechsel in der Entwicklung antiinfektiver Chemotherapeutika. Chemotherapy Journal 1999, 8:69-78.
19. Horne D.D., Frizell M.E., Ingam L., Janas R.G., Gubash S.M., Anand C.M., Athar M.A. Acanthamoeba keratitis an emerging clinical problem. Canadian Medical Association Journal 1994, 150:923-925.
20. Jager B.V., Stamm W.P. Brain abscesses caused by free-living amoeba probably of the genus Hartmannella in a patient with Hodgkins disease. Lancet 1972, 23:1343-1345.
21. Kayser, O., Kiderlen, A., Croft, S.L., 2002. Natural Products as potential antiparasitic drugs. In: Atta-Ur-Rahman. (Ed.), Studies in Natural Product Research, 26, pp. 779-848.
22. Kayser O., Kiderlen A.F., Croft S.L. Natural products as antiparasitic drugs. Parasitology Research 2003, 90:55-62.
23. Khan N.A. Acanthamoeba Biology and Pathogenesis 2009, Caister Academic Press, UK, 85.
24. Kintzios S.E. Oregano, the genera Origanum and Lippia 2002, Taylor and Francis Group, London-New York-Philadelphia-Singapore, 296.
25. Kitagawa K., Nakamura T., Takahashi N., Oikawa Y., Ikeda T. A novel combination treatment of Chlorohexidine gluconate, natamycin (pimaricin) and debridement for a Acanthamoeba keratitis. Japanese Journal of Ophthalmology 2003, 47:616-617.
26. Marciano-Cabral F., Cabral G. Acanthamoeba spp. as agents of disease in humans. Clinical Microbiology Reviews 2003, 16:273-307.
27. Marciano-Cabral F., Puffenbarger R., Cabral G. The increasing importance of Acanthamoeba infections. The Journal of Eukaryot Microbiology 2000, 47:29-36.
28. Martinez A.J., Visvesvara G.S. Free-living, amphizoic and opportunistic amebas. Brain Pathology 1997, 7:583-598.
29. Martinez A.J., Sotelo-Avila C., Garcia-Tamayo J., Moron J.T., Willaert E., Stamm W.P. Meningoencephalitis due to Acanthamoeba spp. Pathogenesis and clinico-pathological study. Acta Neuropathology 1977, 37:183-191.
30. Mattana A., Biancu G., Alberti L., Accardo A., Delogu G., Fiori P.L., Cappuccinelli P. In vitro evaluation of the effectiveness of the macrolide rokitamycin and chlorpromazine against Acanthamoeba castellanii. Antimicrobial Agents and Chemotherapy 2004, 48:4520-4527.
31. Mergeryan H. The prevalence of Acanthamoeba in the human environment. Reviews of Infectious Diseases 1991, 13:S390-S391.
32. Milos M., Mastelic J., Jerkovic I. Chemical composition and antioxidant effect of glycosidically bound volatile compounds from oregano (Origanum vulgare L. spp. hirtum). Food Chemistry 2000, 71:79-83.
33. Mockute D., Bernotiene G., Judzentiene A. The essential oil of Origanum vulgare L. spp. vulgare growing wild in Vilnius district (Lithuania). Phytochemistry 2001, 57:65-69.
34. Murdoch D., Gray T.B., Cursons R., Parr D. Acanthamoeba keratitis in New Zealand, including two cases with in vitro resistance to polyhexamethylene biguanide. Australian and New Zeland Journal of Ophthalmology 1998, 26:231-236.
35. Novak J., Christina B., Langbehn B., Pank F., Skoula M., Gotsiou Y., Franz C.M. Ratios of cis- and trans-sabinene hydrate in Origanum majorana L. and Origanum midrophyllum (Bentham) Vogel. Biochemical Systematics and Ecology 2000, 28:697-704.
36. Osato M.S., Robinson N.M., Wilhelmus K.R., Jones D.B. In vitro evaluation of antimicrobial compounds for cysticidal activity against Acanthamoeba. Reviews of Infectious Diseases 1991, 13(Suppl. 5):S431-S435.
37. Phillipson J.D., Wright C.W. Can ethnopharmacology contribute to the development of antimalarial agents?. Journal of Ethnopharmacology 1991, 32:155-165.
38. Ryman, D., 1992. Aromatherapy, The encyclopaedia of plants and oils and how they help you PIATKUS, London, UK, 163-165.
39. Said Fernández S., Ramos Guerra M.C., Marta Cárdenas B.D., Vargas Villarreal J., Villarreal Treviño L. In vitro antiprotozoal activity of the leaves of Artemisia ludoviciana. Fitoterapia 2005, 76:466-468.
40. Schuster F.L., Visvesvara G.S. Efficacy of novel antimicrobials against clinical isolates of opportunistic amebas. Journal of Eukaryot Microbiology 1998, 45:612-618.
41. Seal D.V. Acanthamoeba keratitis update-incidence, molecular epidemiology and new drugs for treatment. Eye 2003, 17:893-905.
42. Sivropoulou A., Papanikolaou E., Nikolau C., Kokkini S., Lanaras T., Arsenakis M. Antimicrobial and cytotoxic activities of Origanum essential oils. Journal of Agricultural and Food Chemistry 1996, 44:1202-1205.
43. Sokmen A., Jones B.M., Erturk M. The in vitro antibacterial activity of Turkish plants. Journal of Ethnopharmacology 1999, 67:79-86.
44. Szenasi Z., Endo T., Yagita K., Nagy E. Isolation, identification and increasing importance of "free-living" amoebae causing human disease. Journal of Medical Microbiology 1998, 47:5-16.
45. Tan R.X., Zou W.X. Endophytes: a rich source of functional metabolites. Natural Products Reports 2001, 18:448-459.
46. Tepe B., Degerli S., Arslan S., Malatyali E., Sarikurkcu C. Determination of chemical profile, antioxidant, DNA damage protection and antiamoebic activities of Teucrium polium and Stachys iberica. Fitoterapia 2011, 82:237-246.
47. Vera R.R., Chane-Ming J. Chemical composition of the essential oil of marjoram (Origanum majorana L.) from Reunion Island. Food Chemistry 1999, 66:143-145.
48. Visvesvara G.S., Stehr-Green J. Epidemiology of free-living ameba infections. Journal of Protozoology 1990, 37:25S-33S.
49. Walochnik J., Duchêne M., Seifert K., Obwaller A., Hottkowitz T., Wiederman G., Eibl H., Aspöck H. Cytotoxic activities of alkylphosphocholines against clinical isolates of Acanthamoeba spp. Antimicrobiol Agents and Chemotherapy 2002, 46:670-695.
50. Willaert E., Stevens A.R., Healy G.R. Indirect immunofluorescent identification of Acanthamoeba causing meningoencephalitis. Pathologie-Biologie 1976, 24:545-547.